Yu-Tong Zhang Selected Research

Yu-Tong Zhang Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 02/2020
3	Hepatoblastoma 03/2020 - 07/2013
3	Neuroblastoma 02/2019 - 02/2014
2	Pain (Aches) 04/2022 - 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2024
1	Medulloblastoma 08/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Cognitive Dysfunction 01/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Headache (Headaches) 01/2022
1	Lymphangioma (Cavernous Lymphangioma) 01/2022
1	Rupture 01/2022
1	Ascites 12/2021
1	Pleural Effusion (Pleural Effusions) 12/2021
1	Lymphoma (Lymphomas) 12/2021
1	Pericardial Effusion 12/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Wilms Tumor (Wilm's Tumor) 02/2020
1	Capillary Leak Syndrome 02/2020
1	Infections 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 02/2019
1	Muscular Diseases (Myopathy) 12/2018
1	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 10/2018
1	Noninsulin-dependent diabetes mellitus with deafness 07/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 02/2018
1	Inflammation (Inflammations) 01/2017
1	Ganglioneuroblastoma 02/2015
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 02/2015
1	Neoplasm Metastasis (Metastasis) 05/2014
1	Heart Failure 05/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2012

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2020
3	Interleukin-2 (IL2)IBA 01/2022 - 02/2020
3	Vincristine (Oncovin)FDA LinkGeneric 03/2020 - 02/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 03/2020
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2020 - 02/2014
2	Glutamic Acid (Glutamate)FDA Link 10/2018 - 07/2018
2	Transfer RNA (tRNA)IBA 10/2018 - 07/2018
1	Anesthetics (Anesthetic Agents)IBA 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 08/2023
1	HDL CholesterolIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Sirtuin 1IBA 01/2023
1	LDL CholesterolIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	CholesterolIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	SCH 23390IBA 04/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2022
1	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 04/2022
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 04/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histone DemethylasesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2020
1	Gemcitabine FDA Link 02/2020
1	Monoclonal AntibodiesIBA 02/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2020
1	VaccinesIBA 01/2020
1	AntigensIBA 01/2020
1	FilaminsIBA 12/2018
1	NucleotidesIBA 07/2018
1	Glu Transfer RNAIBA 07/2018
1	AcidsIBA 02/2018
1	GlycogenIBA 02/2018
1	alpha-Glucosidases (Acid Maltase)IBA 02/2018
1	SmokeIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	Cisplatin (Platino)FDA LinkGeneric 05/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2013
1	Rituximab (Mabthera)FDA Link 05/2012

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 08/2023 - 05/2012
1	Esophagectomy 01/2024
1	APO protocol 2 01/2022
1	Injections 12/2021
1	Radiofrequency Ablation 03/2020
1	Neoadjuvant Therapy 05/2014